General Information of the Compound
| Compound ID |
CP0211151
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(2-pyridinyl)-3H-benzimidazol-5-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
1H-Benzimidazol-5-amine, 2-(2-pyridinyl)-
1H-Benzimidazol-6-amine, 2-(2-pyridinyl)-
2-(Pyridin-2-yl)-1H-1,3-benzodiazol-6-amine
2-(pyridin-2-yl)-1H-1,3-benzodiazol-5-amine
2-(pyridin-2-yl)-1H-benzo[d]imidazol-5-amine
2-Pyridin-2-yl-1H-benzoimidazol-5-ylamine
2-pyridin-2-yl-3H-benzimidazol-5-amine
55396-63-9
AC1LBVAV
AC1Q52EP
BDBM62926
CHEMBL199925
CTK1F6864
DTXSID50337459
ITFXYBZUPPBWEC-UHFFFAOYSA-N
MLS000528495
MolPort-001-815-306
MolPort-006-709-925
SCHEMBL4371835
SCHEMBL8556415
SMR000121070
cid_542828
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C12H10N4
|
||||||||||||||||||
| Molecular Weight |
210.24
|
||||||||||||||||||
| Canonical SMILES |
Nc1ccc2nc([nH]c2c1)-c1ccccn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C12H10N4/c13-8-4-5-9-11(7-8)16-12(15-9)10-3-1-2-6-14-10/h1-7H,13H2,(H,15,16)
Show/Hide
|
||||||||||||||||||
| InChIKey |
ITFXYBZUPPBWEC-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound